Jim Cramer's Take on Pharma Stocks
During a recent episode of CNBC's “Mad Money Lightning Round,” well-known investor Jim Cramer shared his thoughts on the pharmaceutical sector, discussing several notable players. He specifically highlighted Pfizer Inc. (PFE), advocating that investors should think about increasing their holdings as the company remains a solid option in today’s market.
Positive Outlook for Pfizer
Cramer's positive view on Pfizer follows a report from analyst Louise Chen at Cantor Fitzgerald, who has maintained an Overweight rating for the company with a price target set at $45. This endorsement adds weight to Cramer's bullish perspective on Pfizer, indicating that there’s still potential for the stock to rise.
Concerns About Six Flags
On the flip side, Cramer expressed doubts regarding the future of Six Flags (FUN). He pointed out the challenges the company is facing with its merger, leading him to advise against investing in it. This caution mirrors the opinion of JPMorgan analyst Matthew Boss, who downgraded Six Flags' stock and reduced its price target from $48 to $43.
Focus on First Solar
While discussing various sectors, Cramer also shone a light on the solar energy market, particularly First Solar, Inc. (FSLR). He noted that First Solar is doing well, with BofA Securities raising its price target from $320 to $343, reflecting strong confidence among investors.
High Praise for Equity Residential
In the realm of real estate, Equity Residential (EQR) captured Cramer's attention as an outstanding stock. He referred to the company as a “total winner,” supported by positive projections from various analysts who have raised their price targets based on solid performance metrics.
Moderna's Setbacks
In contrast, Cramer was not optimistic about Moderna, Inc. (MRNA), calling it a “big disappointment.” Even with the recent approval from Health Canada for its COVID-19 vaccine, SPIKEVAX, Cramer believes the company has not lived up to expectations.
Positive Outlook for Vertiv Holdings
When discussing Vertiv Holdings Co. (VRT), Cramer showed optimism, suggesting that investors may find it appealing on any pullback. This is further supported by recent leadership changes at Vertiv, with Frank Poncheri stepping in as chief human resources officer.
Good News for Powell Industries
Cramer also applauded Powell Industries, Inc. (POWL) for its impressive third-quarter results, which surpassed Wall Street's predictions. This strong performance bodes well for potential investors.
Market Trends and Stock Performance
Analyzing market trends, Cramer pointed out several current trading points. Pfizer shares recently dipped slightly to $29.83, down by 0.8%, while Powell Industries experienced a rise of 2.5%, closing at $174.44. First Solar also enjoyed a favorable trend, climbing 2.9% to reach $239.98.
A Deeper Look at Market Dynamics
The fluctuations of these stocks highlight the ever-changing nature of the market. Cramer stresses the importance of staying informed and discovering opportunities, particularly with those that align with future growth trends. For example, the potential for First Solar in renewable energy remains strong, while the traditional pharmaceutical landscape continues to change, pushing companies like Moderna to demonstrate their worth.
Frequently Asked Questions
What did Jim Cramer say about Pfizer?
Cramer expressed strong support for Pfizer, suggesting that investors should buy more stock based on the company’s positive outlook.
How did Cramer view Moderna's performance?
Cramer described Moderna as a “big disappointment” despite the recent approval of its vaccine, indicating the company has not met expectations.
What is Cramer's opinion on First Solar?
Cramer is optimistic about First Solar, highlighting its upward price target revisions and solid market performance.
What is the forecast for Equity Residential?
Cramer called Equity Residential a “total winner,” noting that several analysts have raised price targets, indicating strong investor confidence.
What stock did Cramer mention as worth buying upon a pullback?
Cramer suggested that Vertiv Holdings is a stock investors might consider buying if prices drop, as he sees it as a promising investment.
